New shingles vaccine shows promise in large Long-Term trial
NCT ID NCT07293065
First seen Jan 05, 2026 · Last updated May 22, 2026 · Updated 25 times
Summary
This study tests a new shingles vaccine in 12,000 adults aged 40 and older to see how well it prevents shingles over 1 to 3 years after vaccination. Participants received two shots two months apart. The goal is to confirm the vaccine's long-term protection and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HERPES ZOSTER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hebei Provincial Center for Disease Control and Prevention
Shijiazhuang, Hebei, 050021, China
-
Henan Center for Diseases Control and Prevention
Zhengzhou, Henan, 450016, China
-
Hubei Provincial Center for Disease Control and Prevention
Wuhan, Hubei, 430070, China
-
Yunnan Center For Disease Control and Prevention
Kunming, Yunnan, 650022, China
Conditions
Explore the condition pages connected to this study.